Dennis Goldberg
Login to view DISC.Dennis Goldberg is the CEO of Senex Biotechnology, an experienced drug development expert with a Ph. D. from Temple University. He has a track record of leading biotech firms and was instrumental in developing RenaGel and WelChol. Colleagues describe him as a decisive leader with great technical expertise and strong strategic planning skills.
Outside of his professional work, Dennis shows an interest in societal themes and social justice, reflecting on the messages in dystopian films like "Elysium" and sharing historical quotes about collective responsibility. He appears to be a thoughtful individual concerned with broader human issues beyond science.
Unique fact: He has successfully developed and licensed antibodies for treating prostate cancer and products for acute coronary syndrome.
Read the full overview →How Dennis shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Dennis cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.